Cargando…

Class 1 CF Mutations

Detalles Bibliográficos
Autor principal:	Wilschanski, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379685/ https://www.ncbi.nlm.nih.gov/pubmed/22723780 http://dx.doi.org/10.3389/fphar.2012.00117

Ejemplares similares

The effect of probiotic administration on metabolomics and glucose metabolism in CF patients
por: Gur, Michal, et al.
Publicado: (2022)

Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
por: Ling, Kak-Ming, et al.
Publicado: (2018)

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2022)

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2023)

Survey of CF mutations in the clinical laboratory
por: Huber, Klaus Roland, et al.
Publicado: (2002)

Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease
por: Centorame, Amanda, et al.
Publicado: (2022)

A Green Light for Stop Mutations
por: Cohen-Cymberknoh, Malena, et al.
Publicado: (2021)

Classes of Drugs that Mitigate Radiation Syndromes
por: Micewicz, Ewa D., et al.
Publicado: (2021)

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics
por: Satapornpong, Patompong, et al.
Publicado: (2020)

Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III
por: Zhong, Tiecheng, et al.
Publicado: (2021)

Triarylmethanes, a New Class of Cx50 Inhibitors
por: Bodendiek, Silke B., et al.
Publicado: (2012)

Antimicrobial peptides: a new class of antimalarial drugs?
por: Vale, Nuno, et al.
Publicado: (2014)

Proteoglycans in Biomedicine: Resurgence of an Underexploited Class of ECM Molecules
por: Walimbe, Tanaya, et al.
Publicado: (2020)

ARumenamides: A novel class of potential antiarrhythmic compounds
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability
por: Barbieri, Federica, et al.
Publicado: (2018)

Theoretical insight into OH- and Cl-initiated oxidation of CF(3)OCH(CF(3))(2) and CF(3)OCF(2)CF(2)H & fate of CF(3)OC(X•)(CF(3))(2) and CF(3)OCF(2)CF(2)X• radicals (X=O, O(2))
por: Bai, Feng-Yang, et al.
Publicado: (2017)

The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs
por: Egyed, Attila, et al.
Publicado: (2022)

Probabilistic Pocket Druggability Prediction via One-Class Learning
por: Aguti, Riccardo, et al.
Publicado: (2022)

In silico error correction improves cfDNA mutation calling
por: Kim, Chang Sik, et al.
Publicado: (2019)

Traditional Chinese Medicine: A Class of Potentially Reliable Epigenetic Drugs
por: Zhu, Daoqi, et al.
Publicado: (2022)

Barbiturates and pyrazolopyridines for the treatment of postpartum depression—repurposing of two drug classes
por: Horwitz, Alexander B., et al.
Publicado: (2023)

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
por: Schäfer, Jürgen, et al.
Publicado: (2018)

Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents
por: Peña-Corona, Sheila I., et al.
Publicado: (2023)

Tricaproin Isolated From Simarouba glauca Inhibits the Growth of Human Colorectal Carcinoma Cell Lines by Targeting Class-1 Histone Deacetylases
por: Jose, Asha, et al.
Publicado: (2018)

A Guide to PIN1 Function and Mutations Across Cancers
por: El Boustani, Maguie, et al.
Publicado: (2019)

Calmodulin mutations affecting Gly114 impair binding to the Na(V)1.5 IQ-domain
por: Brohus, Malene, et al.
Publicado: (2023)

Bacterial evolution in PCD and CF patients follows the same mutational steps
por: Sommer, Lea M., et al.
Publicado: (2016)

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization
por: Franco, Rafael, et al.
Publicado: (2016)

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab
por: Garrido, Greta, et al.
Publicado: (2017)

Royleanone Derivatives From Plectranthus spp. as a Novel Class of P-Glycoprotein Inhibitors
por: Garcia, Catarina, et al.
Publicado: (2020)

Clinical Assessments and EEG Analyses of Encephalopathies Associated With Dynamin-1 Mutation
por: Li, Hua, et al.
Publicado: (2019)

Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
por: Abreu, Renata B. V., et al.
Publicado: (2022)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
por: Fairclough, Stephen R., et al.
Publicado: (2019)

Synthesis, structure-activity relationships and biological evaluation of benzimidazole derived sulfonylurea analogues as a new class of antagonists of P2Y1 receptor
por: Bano, Sehrish, et al.
Publicado: (2023)

Diversity of Chromanol and Chromenol Structures and Functions: An Emerging Class of Anti-Inflammatory and Anti-Carcinogenic Agents
por: Wallert, Maria, et al.
Publicado: (2020)

Trifluoromethyl Thianthrenium Triflate: A Readily Available Trifluoromethylating Reagent with Formal CF(3)(+), CF(3)(•), and CF(3)(–) Reactivity
por: Jia, Hao, et al.
Publicado: (2021)

Molecular Mechanisms of Epileptic Encephalopathy Caused by KCNMA1 Loss-of-Function Mutations
por: Yao, Yu, et al.
Publicado: (2022)

Gene therapy for CF.
por: Eubanks, M
Publicado: (2001)

Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells
por: Scherbakov, Alexander M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a3dd48ru56gmtcof7c7f5ejc1u